Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS
NCT07799948 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-09-02
Summary
Refractory hepatic encephalopathy (RHE) after transjugular intrahepatic portosystemic shunt (TIPS) is a serious complication that can markedly impair quality of life and worsen prognosis. Standard medical management-including lactulose, rifaximin, nutritional support, and correction of precipitating factors-is routinely used; however, some patients continue to experience recurrent hepatic encephalopathy despite optimized therapy.
TIPS shunt reduction is an established interventional option for RHE, but current techniques may provide limited ability to precisely control the degree of flow reduction while maintaining procedural safety. The investigators developed a coil-assisted, small-diameter covered-stent technique that deploys coils as an anchor within the existing TIPS tract, followed by placement of a 6-mm balloon-dilated covered stent to achieve controlled reduction in shunt flow.
This single-center ambispective cohort study will evaluate the efficacy and safety of this technique in patients with RHE after TIPS by including both retrospective and prospective cohorts. Outcomes will include hepatic encephalopathy severity and recurrence, stent patency, portal hypertension-related complications, changes in portal pressure gradient, liver function parameters, transplant-free survival, and procedure-related adverse events.
Conditions
- Hepatic Encephalopathy
- Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- Portal Hypertension
- Liver Cirrhosis
Interventions
- PROCEDURE
-
Coil-assisted Small-diameter Stent Shunt reduction
Coil-assisted Small-diameter Stent Shunt reduction: 1. Puncture of the right internal jugular vein, followed by catheter introduction into the existing TIPS stent. 2. Performance of portal venography and measurement of baseline portal pressure gradient. 3. Deployment of a 10-mm coil within the existing TIPS stent as an anchoring point. 4. Delivery and deployment of a 6-mm covered stent within the existing TIPS stent to create a narrowed flow channel. 5. Balloon dilation at both ends of the stent to ensure adequate apposition with the original TIPS stent. 6. Post-procedural portal venography to assess stent patency, portal pressure gradient, and hepatic perfusion.
Sponsors & Collaborators
-
Air Force Military Medical University, China
lead OTHER
Principal Investigators
-
Jun Tie · Air Force Military Medical University, China
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
NCT02026609 ·Status: TERMINATED
-
To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.
NCT03827681 ·Status: UNKNOWN ·Phase: NA
-
Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis
NCT05596253 ·Status: RECRUITING
-
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
NCT06196723 ·Status: COMPLETED
-
TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis
NCT00222014 ·Status: COMPLETED ·Phase: NA
-
Anticoagulation for Advanced Cirrhotic Patients After TIPS
NCT03005444 ·Status: UNKNOWN ·Phase: NA
-
Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy
NCT07634237 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome
NCT02148536 ·Status: COMPLETED
-
Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents
NCT00401895 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.
NCT04013074 ·Status: UNKNOWN ·Phase: NA
-
Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
NCT01559519 ·Status: COMPLETED ·Phase: PHASE4
-
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
NCT07273734 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
NCT04073290 ·Status: RECRUITING ·Phase: PHASE4
-
TIPS for PH Patients: an Observational, Cohort Study
NCT06221982 ·Status: RECRUITING
-
Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients
NCT02427906 ·Status: UNKNOWN
-
Evaluation of the Quality of Life in Patients Referred for Transjugular Intrahepatic Portosystemic Shunt
NCT05204251 ·Status: RECRUITING
-
Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy
NCT07553858 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
NCT01773538 ·Status: COMPLETED ·Phase: NA
-
Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy
NCT05070351 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism
NCT07490405 ·Status: NOT_YET_RECRUITING
-
Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
NCT01379469 ·Status: TERMINATED ·Phase: PHASE2
-
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis
NCT07755059 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
NCT02016196 ·Status: COMPLETED ·Phase: PHASE3
-
TIPS With or Without BCAA
NCT07281846 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure
NCT01582087 ·Status: TERMINATED